Based on epidemiologic studies showing association of lower cholesterol levels to hemorrhagic stroke including subarachnoid hemorrhage [28-30], it may be speculated that lipid metabolism involving APOE contributes to risk of SAH or its adverse outcomes. This evidence concerns the gene APOE and subarachnoid hemorrhage.